Vanguard Personalized Indexing Management, LLC Lexicon Pharmaceuticals, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.46 Billion
- Q4 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 23,223 shares of LXRX stock, worth $7,895. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,223
Previous 19,922
16.57%
Holding current value
$7,895
Previous $31,000
45.16%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding LXRX
# of Institutions
133Shares Held
245MCall Options Held
52KPut Options Held
178K-
Artal Group S.A. Luxembourg, N4136MShares$46.3 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$13.2 Million1.27% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$3.36 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$3.36 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct8.99MShares$3.06 Million0.02% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $64.2M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...